Detection of macrolide-resistance mutations in 23S rRNA gene of Mycoplasma pneumoniae using a novel real-time PCR assay
Abstract
About the Authors
I. A. EdelsteinRussian Federation
M. V. Edelstein
Russian Federation
A. V. Romanov
Russian Federation
S. A. Ratchina
Russian Federation
S. B. Yatsyshina
Russian Federation
I. V. Rakovskaja
Russian Federation
R. S. Kozlov
Russian Federation
References
1. Бобылев А.А., Рачина С.А., Эйдельштейн И.А. [и др.] Описание вспышки инфекции, вызванной Mycoplasma pneumoniae, в Смоленской области // Пульмонология. 2013. Т. 5. С. 97-100.
2. Эйдельштейн И.И., Эйдельштейн М.В., Романов А.В. [и др.] Оценка распространенности «классических» механизмов устойчивости к фторхинолонам у Chlamydia trachomatis, связанных с мутациями в генах топоизомераз // Клиническая микробиология и антимикробная химиотерапия. 2014. Т. 16, № 4. С. 301-307.
3. Averbuch D., Hidalgo-Grass C., Moses A. [et al.] Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010 // Emerging Infectious Diseases (Centers for Disease Control and Prevention). 2011. Vol. 17, No. 6. P. 1079-1082.
4. Clinical and Laboratory Standards Institute. 2011. Methods for antimicrobial susceptibility testing of human mycoplasmas. Approved Guideline M43-A. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Dumke R., von Baum H., Lück P [et al.] Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany // Eur. J. Clin. Microbiol. Infect. Dis. 2010. Vol. 16, No. 6. P. 613-616.
6. Dumke R., Stolz S., Jacobs E. [et al.] Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia // Int. J. Infect. Dis. 2014. Vol. 29. P. 197-199.
7. Godron A., Pereyre S., Monet C. [et al.] Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection // Pediatr. Nephrol. 2013. Vol. 28, No. 10. P. 2057-2060.
8. Hantz S., Garnier F., Peuchant O. [et al.] Multilocus variablenumber tandem-repeat analysis-confirmed emergence of a mac-rolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child // Journal of Clinical Microbiology. 2012. Vol. 50, No. 10. P 3402-3405.
9. Li X., Atkinson T., Hagood J. [et al.] Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates // Pediatric Infectious Disease Journal. 2009. Vol. 28, No. 8. P. 693-696.
10. Mayumi M., Mitsuo N., Norio O. [et al.] Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan // Antimicrob. Agents Chemother. 2004. Vol. 48, No. 12. P. 4624-4630.
11. Mulholland S., Gavranich J., Gillies M., Chang A.B. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children // Cochrane Database Syst. Rev. 2012. Vol. 12, No. 9. DOI: 10.1002/14651858.CD004875.pub4.
12. Peuchant O., Ménard A., Renaudin H. [et al.] Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis // Journal of Antimicrobial Chemotherapy. 2009. Vol. 64, No. 1. P. 52-58.
13. Spuesens E., Hoogenboezem T., Sluijter M. [et al.] Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing // J. Microbiol. Methods. 2010. Vol. 82, No. 3 P. 214-222
14. Spuesens E., Meijer A., Bierschenk D. [et al.] Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands // Journal of Clinical Microbiology. 2012. Vol. 50, No. 6. P. 1999-2004.
15. Waites K., Talkington D. Mycoplasma pneumoniae and its role as a human pathogen // Clin. Microbiol. Rev. 2004. Vol. 17, No. 4. P. 697-728.
Review
For citations:
Edelstein I.A., Edelstein M.V., Romanov A.V., Ratchina S.A., Yatsyshina S.B., Rakovskaja I.V., Kozlov R.S. Detection of macrolide-resistance mutations in 23S rRNA gene of Mycoplasma pneumoniae using a novel real-time PCR assay. Pacific Medical Journal. 2015;(1):63-66. (In Russ.)